肠道菌群改变与胆固醇结石病

doi:10.16139/j.1007-9610.2019.02.001

外科理论与实践 ›› 2019, Vol. 24 ›› Issue (02): 93-95.doi: 10.16139/j.1007-9610.2019.02.001

• 专家论坛 • 下一篇

肠道菌群改变与胆固醇结石病

蒋兆彦¹, 胡海¹, 韩天权², 张圣道²

1.同济大学附属东方医院胆石病中心,同济大学医学院胆石病研究所,上海 201200;
2.上海交通大学医学院附属瑞金医院外科,上海消化外科研究所,上海 200025

收稿日期:2019-02-20 出版日期:2019-03-25 发布日期:2019-04-25
通讯作者: 蒋兆彦,E-mail: zhaoyanjiang@gmail.com
基金资助:
国家自然科学基金（81570574,81570577, 81670579）

Alteration of gut microbiota and pathogenesis of cholelithiasis

JIANG Zhaoyan¹, HU Hai¹, HAN Tianquan², ZHANG Shengdao²

Received:2019-02-20 Online:2019-03-25 Published:2019-04-25

摘要/Abstract

中图分类号:

R657.4⁺2

蒋兆彦, 胡海, 韩天权, 张圣道. 肠道菌群改变与胆固醇结石病[J]. 外科理论与实践, 2019, 24(02): 93-95.

[1] 王启晗, 张中文, 吴健, 等. 上海地区胆囊结石病的流行病学调查[J]. 外科理论与实践,2018,23(3):252-257.
[2] Rebholz C, Krawczyk M, Lammert F.Genetics of gallstone disease[J]. Eur J Clin invest,2018,48(7):e12935.
[3] 蒋兆彦, 胡海, 韩天权, 等. 胆固醇的肠肝循环:肝脏和小肠在胆石形成中的作用[J]. 外科理论与实践,2017, 22(3):191-194.
[4] Katsika D, Grjibovski A, Einarsson C, et al.Genetic and environmental influences on symptomatic gallstone di-sease: a Swedish study of 43,141 twin pairs[J]. Hepato-logy,2005,41(5):1138-1143.
[5] Lammert F, Carey MC, Paigen B, et al.Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map[J]. Gastroenterology,2001,120(1):221-238.
[6] Grünhage F, Acalovschi M, Tirziu S, et al.Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol[J]. Hepatology,2007,46(3):793-801.
[7] Lauridsen BK, Stender S, Tybjærg-Hansen A.Genetic variation in NPC1L1 and risk of gallstone disease[J]. J Am Coll Cardiol,2015,66(9):1086.
[8] Tilg H, Moschen AR.Microbiota and diabetes: an evol-ving relationship[J]. Gut,2014,63(9):1513-1521.
[9] Ridaura VK, Faith JJ, Rey FE, et al.Gut microbiota from twins discordant for obesity modulate metabolism in mice[J]. Science,2013,341(6150):1241214.
[10] Henao-Mejia J, Elinav E, Jin C, et al.Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J]. Nature,2012,482(7384):179-185.
[11] Canfora EE, Jocken JW, Blaak EE.Short-chain fatty acids in control of body weight and insulin sensitivity[J]. Nat Rev Endocrinol,2015,11(10):577-591.
[12] Frey C, Thorpe C, Abrams G.Gallstone formation in the germ-free mouse[J]. Am J Surg,1968,115(1):75-81.
[13] Fremont-Rahl JJ, Ge Z, Umana C, et al.An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis[J]. PLoS One,2013,8(7):e70657.
[14] Wang Q, Jiao L, He C, et al.Alteration of gut microbiota in association with cholesterol gallstone formation in mice[J]. BMC Gastroenterol,2017,17(1):74.
[15] Kurdi P, Kawanishi K, Mizutani K, et al.Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria[J]. J Bacteriol,2006,188(5):1979-1986.
[16] Islam KB, Fukiya S, Hagio M, et al.Bile acid is a host factor that regulates the composition of the cecal microbiota in rats[J]. Gastroenterology,2011,141(5):1773-1781.
[17] Sayin SI, Wahlström A, Felin J, et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist[J]. Cell Metab,2013,17(2):225-235.
[18] Hu X, Bonde Y, Eggertsen G, et al.Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism[J]. J Intern Med,2014,275(1):27-38.
[19] Wahlström A, Kovatcheva-Datchary P, Ståhlman M, et al.Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota[J]. J Lipid Res,2017,58(2):412-419.
[20] Degirolamo C, Rainaldi S, Bovenga F, et al.Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice[J]. Cell Rep,2014,7(1):12-18.
[21] Gregory JC, Buffa JA, Org E, et al.Transmission of atherosclerosis susceptibility with gut microbial transplantation[J]. J Biol Chem,2015,290(9):5647-5660.
[22] Zhao L, Zhang F, Ding X, et al.Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J]. Science,2018,359(6380):1151-1156.
[23] Chu H, Duan Y, Yang L, et al.Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease[J]. Gut,2019,68(2):359-370.
[24] Hoyles L, Fernández-Real JM, Federici M, et al.Mole-cular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women[J]. Nat Med,2018,24(7):1070-1080.
[25] Koeth RA, Wang Z, Levison BS, et al.Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis[J]. Nat Med,2013,19(5):576-585.
[26] Wang Z, Klipfell E, Bennett BJ, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature,2011,472(7341):57-63.
[27] Garidou L, Pomié C, Klopp P, et al.The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease[J]. Cell Metab,2015,22(1):100-112.
[28] Tedesco D, Thapa M, Chin CY, et al.Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic γδ T-cell receptor-positive cells and pathogenesis of cholestatic liver disease[J]. Gastroentero-logy,2018,154(8):2178-2193.
[29] Maurer KJ, Rao VP, Ge Z, et al.T-cell function is critical for murine cholesterol gallstone formation[J]. Gastroenterology,2007,133(4):1304-1315.

肠道菌群改变与胆固醇结石病

Alteration of gut microbiota and pathogenesis of cholelithiasis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	段中华, 王宇华, 郭斯敏. 牙周病在非酒精性脂肪性肝病中的作用及机制研究进展[J]. 内科理论与实践, 2023, 18(02): 107-110.
[2]	潘柔百, 宗枭, 陶蓉. 益生菌对心室重构的影响[J]. 内科理论与实践, 2023, 18(02): 131-134.
[3]	陈聪燕综述, 王俊青, 陈拥军审校. 肠道菌群与肝癌的发病机制[J]. 外科理论与实践, 2022, 27(03): 256-260.
[4]	许飞, 尹明月, 王伟, 董治亚, 陆文丽, 余熠, 王歆琼, 王俊祺, 肖园. 性早熟女童肠道菌群和抗生素耐药性的宏基因组分析[J]. 诊断学理论与实践, 2022, 21(01): 52-61.
[5]	高铭, 李娜, 刘煜. 脑-肠轴与2型糖尿病相关性的研究进展[J]. 内科理论与实践, 2021, 16(06): 418-421.
[6]	李林, 安静静, 王俊祺, 王歆琼, 董治亚. 16S rRNA第二代测序技术分析特发性身材矮小儿童肠道菌群构成的特征及相关发病机制研究[J]. 诊断学理论与实践, 2021, 20(02): 149-154.
[7]	李惠, 冯洁, 韩立中. 高通量测序技术分析无特定病原体级实验小鼠肠道的菌群组成[J]. 诊断学理论与实践, 2020, 19(1): 55-62.
[8]	安静静, 王俊祺, 肖园, 陆文丽, 李林, 王伟, 董治亚. 16S rRNA高通量测序分析肠道菌群对小于胎龄大鼠生长追赶的影响及其可能的机制[J]. 诊断学理论与实践, 2020, 19(04): 375-380.
[9]	张雪莹, 秦环龙. 肠道菌群作为结肠直肠癌生物标志物及其干预的临床意义[J]. 外科理论与实践, 2020, 25(02): 155-158.
[10]	陈瑶瑶, 顾爱华. 氧化三甲胺与心血管疾病关系的研究进展[J]. 诊断学理论与实践, 2019, 18(2): 237-240.
[11]	陆启帆, 蒋兆彦, 王启晗, 赵刚, 胡海. 牛磺熊去氧胆酸预防高脂饮食小鼠胆囊结石的研究[J]. 外科理论与实践, 2019, 24(06): 522-529.
[12]	陈超波, 蒋兆彦. 胆汁酸代谢与非酒精性脂肪性肝病[J]. 外科理论与实践, 2019, 24(04): 371-374.
[13]	汪婷婷, 郑乃盛, 袁向亮, 沈立松. 基于16S rRNA高通量测序技术分析小鼠实验性结肠炎肠道菌群结构特征[J]. 诊断学理论与实践, 2019, 18(03): 263-270.
[14]	陆伦根, 胡江峰,. 肠道菌群与胆汁酸的研究进展[J]. 内科理论与实践, 2018, 13(06): 329-333.
[15]	陈施吾, 王刚,. 帕金森病与肠道菌群关系的研究进展[J]. 内科理论与实践, 2018, 13(05): 316-319.